多瑞医药(301075)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301075 多瑞医药

已收盘 05-17 15:00:00

{"stockData":{"symbol":"301075","market":"SZ","secType":"STK","nameCN":"多瑞医药","latestPrice":19.65,"timestamp":1715929413000,"preClose":19.61,"halted":0,"volume":897100,"delay":0,"floatShares":27423700,"shares":80000000,"eps":0.2342,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"05-17 15:00:00","open":19.6,"high":19.79,"low":19.3,"amount":17524000,"amplitude":0.025,"askPrice":19.67,"askSize":2,"bidPrice":19.65,"bidSize":29,"shortable":0,"etf":0,"ttmEps":0.2342,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":19.61,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":21.57,"lowLimit":17.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":80000000,"pbRate":2.09,"roa":"--","roe":"--","epsLYR":0.24,"committee":-0.062937,"marketValue":1572000000,"floatMarketCap":539000000,"peRate":83.902647,"changeRate":0.002,"turnoverRate":0.0327,"status":0},"requestUrl":"/m/hq/s/301075/tweets","defaultTab":"tweets","newsList":[{"id":"2434833485","title":"多瑞医药：公司暂无相关领域的布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2434833485","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434833485?lang=zh_cn&edition=full","pubTime":"2024-05-10 17:05","pubTimestamp":1715331953,"startTime":"0","endTime":"0","summary":"证券之星消息，多瑞医药(301075)05月10日在投资者关系平台上答复投资者关心的问题。投资者：请问贵公司有合成生物相关领域的研究吗多瑞医药董秘：您好！感谢您的关注！公司暂无相关领域的布局，谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000031973.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430631282","title":"多瑞医药（301075）2024年一季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2430631282","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430631282?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:31","pubTimestamp":1714084281,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期多瑞医药发布2024年一季报。根据财报显示，本报告期中多瑞医药增收不增利。其中，毛利率39.48%，同比减39.02%，净利率-4.56%，同比减41.15%，销售费用、管理费用、财务费用总计3350.5万元，三费占营收比42.7%，同比减28.88%，每股净资产9.37元，同比减0.99%，每股经营性现金流-0.16元，同比减173.09%，每股收益-0.03元。公司最新一期年度报表的现金流为正，经营性现金流和利润稍微不匹配，问题不大。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600014041.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429862435","title":"多瑞医药(301075.SZ)发布一季度业绩，净亏损253.73万元，同比扩大4.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429862435","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429862435?lang=zh_cn&edition=full","pubTime":"2024-04-24 18:24","pubTimestamp":1713954263,"startTime":"0","endTime":"0","summary":"智通财经APP讯，多瑞医药(301075.SZ)发布2024年第一季度报告，营业收入7845.74万元，同比增长0.48%;归属于上市公司股东的净亏损253.73万元，同比扩大4.97%;归属于上市公司股东的扣除非经常性损益的净亏损374.93万元，同比扩大1.4%;基本每股亏损0.03元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108742.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2404333679","title":"多瑞医药：拟投资取得红熙医疗51%股权 进一步丰富公司业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2404333679","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2404333679?lang=zh_cn&edition=full","pubTime":"2024-01-17 18:38","pubTimestamp":1705487924,"startTime":"0","endTime":"0","summary":"多瑞医药（301075）公告称，为进一步丰富公司业务布局，创造新的利润增长点，公司近日签订《投资合作协议》，公司以0万元受让李占兵、田彬、张恒瑞、熊荣亮持有的红熙医疗科技（天津）有限公司51%的股权（未实缴），对应注册资本510万元。公司将向红熙医疗出资510万元，履行实缴出资的义务。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65a7aefd53243c07837546cb","is_publish_highlight":false,"gpt_icon":0},{"id":"2404830313","title":"多瑞医药(301075.SZ)拟控股红熙医疗 进入慢性肾病管理领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2404830313","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2404830313?lang=zh_cn&edition=full","pubTime":"2024-01-17 15:53","pubTimestamp":1705477980,"startTime":"0","endTime":"0","summary":"多瑞医药公告，公司近日签订了《投资合作协议》，公司以0万元受让李占兵、田彬、张恒瑞、熊荣亮持有的红熙医疗科技(天津)有限公司51%的股权(未实缴)，对应注册资本510万元。公司将向红熙医疗出资510万元，履行实缴出资的义务。本次股权转让完成后，公司持有红熙医疗51%股权，红熙医疗为公司控股子公司。本次对外投资有利于公司进入慢性肾病管理领域，为公司创造新的利润增长点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-17/doc-inacvpix6383922.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-17/doc-inacvpix6383922.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-09-29","address":"西藏自治区昌都市卡若区昌都经济开发区A区(泰铭生物科技)","stockEarnings":[{"period":"1week","weight":-0.0145},{"period":"1month","weight":0.0844},{"period":"3month","weight":0.3386},{"period":"6month","weight":-0.3203},{"period":"1year","weight":-0.2309},{"period":"ytd","weight":-0.2632}],"companyName":"西藏多瑞医药股份有限公司","boardCode":"AI0027","perCapita":"2848股","boardName":"医药制造业","registeredCapital":"8000万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　西藏多瑞医药股份有限公司主要从事化学药品制剂及其原料药的研发、生产和销售业务。公司的主要产品为醋酸钠林格注射液等。","serverTime":1716055338832,"listedPrice":27.27,"stockholders":"9628人(较上一季度减少9.30%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"多瑞医药(301075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供多瑞医药(301075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"多瑞医药,301075,多瑞医药股票,多瑞医药股票老虎,多瑞医药股票老虎国际,多瑞医药行情,多瑞医药股票行情,多瑞医药股价,多瑞医药股市,多瑞医药股票价格,多瑞医药股票交易,多瑞医药股票购买,多瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"多瑞医药(301075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供多瑞医药(301075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}